Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Nashville TN, Birmingham AL, Atlanta GA,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07069673
Recruiting
New
Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
for
HNSCC, SCC - Squamous Cell Carcinoma, Oral Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT07741565
Early Phase 1, Recruiting
New
Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
for
HNSCC,Larynx, Pharynx and Oral Cavity, Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT07741643
Phase 1, Recruiting
New
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
for
Refractory Clear Cell Renal Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07748988
Phase 1, Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Nashville TN, Iowa City IA, Hamilton, Houston TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase 1, Phase 2, Recruiting
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Location: Nashville TN, Birmingham AL, Atlanta GA, St Louis MO,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50+
Code: NCT06455085
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions